Transmembrane glucose transport in skeletal muscle of patients with non-insulin-dependent diabetes.
Open Access
- 1 July 1993
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 92 (1) , 486-494
- https://doi.org/10.1172/jci116592
Abstract
Insulin resistance for glucose metabolism in skeletal muscle is a key feature in non-insulin-dependent diabetes mellitus (NIDDM). Which cellular effectors of glucose metabolism are involved is still unknown. We investigated whether transmembrane glucose transport in vivo is impaired in skeletal muscle in nonobese NIDDM patients. We performed euglycemic insulin clamp studies in combination with the forearm balance technique (brachial artery and deep forearm vein catheterization) in six nonobese NIDDM patients and five age- and weight-matched controls. Unlabeled D-mannitol (a nontransportable molecule) and radioactive 3-O-methyl-D-glucose (the reference molecular probe to assess glucose transport activity) were simultaneously injected into the brachial artery, and the washout curves were measured in the deep venous effluent blood. In vivo transmembrane transport of 3-O-methyl-D-glucose in forearm muscle was determined by computerized analysis of the washout curves. At similar steady-state plasma concentrations of insulin (approximately 500 pmol/liter) and glucose (approximately 5.15 mmol/liter), transmembrane inward transport of 3-O-methyl-D-glucose in skeletal muscle was markedly reduced in the NIDDM patients (6.5 x 10(-2) +/- 0.56 x 10(-2).min-1) compared with controls (12.5 x 10(-2) +/- 1.5 x 10(-2).min-1, P < 0.005). Mean glucose uptake was also reduced in the diabetics both at the whole body level (9.25 +/- 1.84 vs. 28.3 +/- 2.44 mumol/min per kg, P < 0.02) and in the forearm tissues (5.84 +/- 1.51 vs. 37.5 +/- 7.95 mumol/min per kg, P < 0.02). When the latter rates were extrapolated to the whole body level, skeletal muscle accounted for approximately 80% of the defect in insulin action seen in NIDDM patients. We conclude that transmembrane glucose transport, when assessed in vivo in skeletal muscle, is insensitive to insulin in nonobese NIDDM patients, and plays a major role in determining whole body insulin resistance.Keywords
This publication has 55 references indexed in Scilit:
- Effect of insulin on system A amino acid transport in human skeletal muscle.Journal of Clinical Investigation, 1993
- Decreased expression of glucose transporter in muscle from insulin-resistant patientsAmerican Journal of Physiology-Endocrinology and Metabolism, 1991
- Multiple defects in muscle glycogen synthase activity contribute to reduced glycogen synthesis in non-insulin dependent diabetes mellitus.Journal of Clinical Investigation, 1991
- Identification of a novel gene encoding an insulin-responsive glucose transporter proteinCell, 1989
- An in vitro human muscle preparation suitable for metabolic studies. Decreased insulin stimulation of glucose transport in muscle from morbidly obese and diabetic subjects.Journal of Clinical Investigation, 1988
- Effect of physiologic hyperinsulinemia on skeletal muscle protein synthesis and breakdown in man.Journal of Clinical Investigation, 1987
- Substrate regulation of the glucose transport system in rat skeletal muscle. Characterization and kinetic analysis in isolated soleus muscle and skeletal muscle cells in culture.Journal of Biological Chemistry, 1986
- Insulin sensitivity in adipocytes from subjects with varying degrees of glucose toleranceAmerican Journal of Physiology-Endocrinology and Metabolism, 1986
- The relative proportions of fat, muscle and bone in the normal human forearm as determined by computed tomographyClinical Science, 1984
- Evidence that insulin causes translocation of glucose transport activity to the plasma membrane from an intracellular storage site.Proceedings of the National Academy of Sciences, 1980